This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Mankind, Bharat Serums seek India nod for merger clearance

By Freny Patel ( August 12, 2024, 00:13 GMT | Insight) -- Pharmaceutical major Mankind Pharma has sought approval from the Indian antitrust watchdog to acquire Bharat Serums and Vaccines, with the private-equity firm Advent International planning to fully divest its shareholding in Bharat Serums for $1.7 billion. The merger, filed under form 11, could face scrutiny from the Competition Commission of India due to potential overlaps in the horizontal and vertical markets, according to the three-page merger filing.Pharmaceutical major Mankind Pharma has sought approval from the Indian antitrust watchdog to acquire Bharat Serums and Vaccines, with the private equity firm Advent International planning to fully divest its shareholding in Bharat Serums for 136.3 billion rupees ($1.7 billion)....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login